Home Healthcare IT Cell and Gene Therapy Manufacturing QC Market Size, Sghare And Growth Analysis by 2033

Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2033

Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy [CAR-T {Autologous CAR-T, Allogeneic CAR-T}, CAR-NK, B-Cell, & Others], and Gene Therapy [Viral {AAV, Lenti, and Other}, Non-Viral]), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America) Forecasts, 2025-2033

Report Code: SRHI2260DR
Last Updated : May, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Cell and Gene Therapy Manufacturing QC Market Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. U.S.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Canada
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. U.K.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Germany
    11. France
    12. Spain
    13. Italy
    14. Russia
    15. Nordic
    16. Benelux
    17. Rest of Europe
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. China
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Korea
    11. Japan
    12. India
    13. Australia
    14. Taiwan
    15. South East Asia
    16. Rest of Asia-Pacific
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. UAE
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Turkey
    11. Saudi Arabia
    12. South Africa
    13. Egypt
    14. Nigeria
    15. Rest of MEA
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
        2. CAR-T
          1. CAR-T By Value
          2. Autologous CAR-T
            1. Autologous CAR-T By Value
          3. Allogeneic CAR-T
            1. Allogeneic CAR-T By Value
        3. CAR-NK
          1. CAR-NK By Value
        4. B-Cell
          1. B-Cell By Value
        5. Others
          1. Others By Value
      3. Gene Therapy
        1. By Value
        2. Viral
          1. Viral By Value
          2. AAV
            1. AAV By Value
          3. Lentiviral vectors
            1. Lentiviral vectors By Value
          4. Other
            1. Other By Value
        3. Non-Viral
          1. Non-Viral By Value
    3. By Scale
      1. Introduction
        1. Scale By Value
      2. Pre-commercial/ R&D Manufacturing
        1. By Value
      3. Commercial Scale Manufacturing
        1. By Value
    4. By Mode
      1. Introduction
        1. Mode By Value
      2. Contract Manufacturing
        1. By Value
      3. In-house Manufacturing
        1. By Value
    5. By Workflow
      1. Introduction
        1. Workflow By Value
      2. Cell Processing
        1. By Value
      3. Cell Banking
        1. By Value
      4. Fill & Finish Operations
        1. By Value
      5. Raw Material Testing
        1. By Value
      6. Vector Production
        1. By Value
      7. Other Workflows
        1. By Value
    6. By Process
      1. Introduction
        1. Process By Value
      2. Upstream Processes
        1. By Value
      3. Downstream Processes
        1. By Value
    7. By End-User
      1. Introduction
        1. End-User By Value
      2. Pharmaceutical Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      3. Biopharmaceutical / Biotechnological Companies
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
      4. Contract Manufacturing Organizations
        1. By Value
        2. Small Size
          1. Small Size By Value
        3. Medium Size
          1. Medium Size By Value
        4. Large Size
          1. Large Size By Value
    8. By Technology Type
      1. Introduction
        1. Technology Type By Value
      2. Fluorescence-Activated Cell Sorting (FACS)
        1. By Value
      3. Enzyme-Linked Immunosorbent Assay (ELISA)
        1. By Value
      4. Chromatography
        1. By Value
      5. Next-Generation Sequencing (NGS)
        1. By Value
      6. Polymerase Chain Reaction (PCR)
        1. By Value
      7. Others
        1. By Value
    9. Brazil
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
          2. CAR-T
            1. CAR-T By Value
            2. Autologous CAR-T
              1. Autologous CAR-T By Value
            3. Allogeneic CAR-T
              1. Allogeneic CAR-T By Value
          3. CAR-NK
            1. CAR-NK By Value
          4. B-Cell
            1. B-Cell By Value
          5. Others
            1. Others By Value
        3. Gene Therapy
          1. By Value
          2. Viral
            1. Viral By Value
            2. AAV
              1. AAV By Value
            3. Lentiviral vectors
              1. Lentiviral vectors By Value
            4. Other
              1. Other By Value
          3. Non-Viral
            1. Non-Viral By Value
      2. By Scale
        1. Introduction
          1. Scale By Value
        2. Pre-commercial/ R&D Manufacturing
          1. By Value
        3. Commercial Scale Manufacturing
          1. By Value
      3. By Mode
        1. Introduction
          1. Mode By Value
        2. Contract Manufacturing
          1. By Value
        3. In-house Manufacturing
          1. By Value
      4. By Workflow
        1. Introduction
          1. Workflow By Value
        2. Cell Processing
          1. By Value
        3. Cell Banking
          1. By Value
        4. Fill & Finish Operations
          1. By Value
        5. Raw Material Testing
          1. By Value
        6. Vector Production
          1. By Value
        7. Other Workflows
          1. By Value
      5. By Process
        1. Introduction
          1. Process By Value
        2. Upstream Processes
          1. By Value
        3. Downstream Processes
          1. By Value
      6. By End-User
        1. Introduction
          1. End-User By Value
        2. Pharmaceutical Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        3. Biopharmaceutical / Biotechnological Companies
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
        4. Contract Manufacturing Organizations
          1. By Value
          2. Small Size
            1. Small Size By Value
          3. Medium Size
            1. Medium Size By Value
          4. Large Size
            1. Large Size By Value
      7. By Technology Type
        1. Introduction
          1. Technology Type By Value
        2. Fluorescence-Activated Cell Sorting (FACS)
          1. By Value
        3. Enzyme-Linked Immunosorbent Assay (ELISA)
          1. By Value
        4. Chromatography
          1. By Value
        5. Next-Generation Sequencing (NGS)
          1. By Value
        6. Polymerase Chain Reaction (PCR)
          1. By Value
        7. Others
          1. By Value
    10. Mexico
    11. Argentina
    12. Chile
    13. Colombia
    14. Rest of LATAM
    1. Cell and Gene Therapy Manufacturing QC Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. WuXi AppTec
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Lonza
    3. Thermo Fisher Scientific
    4. Charles River Laboratories
    5. Catalent
    6. Merck KGaA
    7. Eurofins Scientific
    8. Pace
    9. Pharmaron
    10. BioAgilytix Labs
    11. Avance Biosciences
    12. SGS
    13. IQVIA
    14. Alcami Corporation
    15. Solvias
    16. Pacific BioLabs
    17. ProtaGene
    18. Laboratory Corporation of America Holdings
    19. AGC Biologics
    20. uBriGene Biosciences International Co.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.